Investment Column: Michael Page deserves its premium rating

Victrex; UK Mail


Our view: Hold

Share price: 463.4p (-15p)

Our faith in Michael Page paid off with bells on yesterday. The group released an impressive trading statement (third-quarter gross profit of £112.7m was up 37 per cent) and has more than repaid the faith of those who stuck by management's fierce resistance to an attempted takeover by Swiss rival Adecco two years ago.

Page has also served those who followed this column's buy recommendation in May well – the shares have risen by nearly 10 per cent since then. What encourages us about the stock is chief executive Steve Ingham's take on the outlook. He says the group's lead indicators (the number of job vacancies, for example) are not suggesting any signs of a slowdown, quite the reverse. Ingham, who knows the business like the back of his hand, is pretty straight as chief executives go.

And perhaps he has good reason to feel optimistic. Jobs are being created in those parts of the world where the economic outlook is broadly positive (Asia, Latin America, etc). It's more shaky in the West, not least because of the deficit issue, which is a problem just about everywhere you would care to think of. However, the business is still being sustained by churn – that is, people shifting between jobs.

That is not going away. Indeed, just this week PricewaterhouseCoopers issued research suggesting that there's going to be a lot more of it in Britain as workers who've stayed put during the downturn, wearing problems such as pay freezes and longer hours, decide that they've had enough and start looking to move on.

At 30 times 2010 forecast earnings, yielding 1.7 per cent, the shares are hardly cheap, and sit at a premium to the sector (on about 23 times). This is not undeserved: Page's management is strong, and its international reach, already very handy, just keeps on growing. At their current level, however, the shares could see some profit-taking. We would hold for now but wade in on any signs of weakness.

Victrex

Our view: Hold

Share price: 1,286p (-37p)

Victrex, the world's biggest supplier of PEEK polymer, said sales were up by a whopping 64 per cent to 2,535 tonnes when it published a full-year trading update yesterday. The company was helped by a record second half. Invibio Victrex's biomaterials business, which contributes about a third of profits, also performed in line with expectations, with revenues increasing by 29 per cent to £44m.

So far, so good, then. And it is quite likely that there is to be more to come. Even allowing for the boost provided by post-recession restocking, 2010 has been a good year for Victrex. And City analysts are expecting a special dividend of anything up to £50m, probably early next year, thanks to a rising net cash position.

Next year's trading is likely to be trickier than the bumper 2010, as the benefits from the weak pound fall off and the boom from restocking normalises. Invibio could also be hit by declining healthcare budgets in both the UK and the US. But the company is well-positioned and James Tetley, an analyst at Brewin Research, believes the current price of 11 times next year's earnings estimates will not be prohibitive to a takeover bid.

The stock has added the best part of 60 per cent since our last hold recommendation. But we are with Mr Tetley when he describes the company as a "core sector holding". We think there is room for further gains in the price, before it is time to take profits and look elsewhere. So keeping holding.

UK Mail

Our view: Buy

Share price: 384p (unchanged)

If readers can excuse the obvious pun, UK Mail has delivered. As its cumbersome rival, the publicly owned (for the time being) Royal Mail, has struggled through union battles and political rows, UK Mail has made impressive progress, manifesting in a 27 per cent share price hike for investors in the past 12 months.

In a trading statement the group said yesterday that the first half of the year had "been satisfactory" ahead of the busy fourth quarter. The group's parcels business, the retail logistics unit and the courier division all put in strong performances.

We regard UK Mail as something of a banker. The stock continues to make steady progress, the company will continue taking business away from Royal Mail and with a generous-looking dividend yield of 5 per cent, the returns look impressive. On a price to earnings basis, UK Mail does look a little toppy, trading on 15.2 times March 2011 forecast earnings, but we would argue that the yield should soothe any fears that the stock will tread water for the foreseeable future. We continue to back UK Mail. Buy.

Start your day with The Independent, sign up for daily news emails
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Payments Operations Assistant

£23000 - £25000 per annum: Recruitment Genius: They win lots of awards for the...

Recruitment Genius: Telephone Debt Negotiator

£13500 - £20000 per annum: Recruitment Genius: This nationwide enforcement com...

Guru Careers: Communications Exec / PR Exec

£25 - £30K: Guru Careers: We are seeking a highly-motivated and ambitious Comm...

Guru Careers: Pricing Analyst

£30 - 35k: Guru Careers: We are seeking a Pricing Analyst to join a leading e-...

Day In a Page

On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

On your feet!

Spending half the day standing 'reduces risk of heart attacks and cancer'
Liverpool close in on Milner signing

Liverpool close in on Milner signing

Reds baulk at Christian Benteke £32.5m release clause
With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

The big NHS question

Why are there so few new GPs when so many want to study medicine?
Big knickers are back: Thongs ain't what they used to be

Thongs ain't what they used to be

Big knickers are back
Thurston Moore interview

Thurston Moore interview

On living in London, Sonic Youth and musical memoirs
In full bloom

In full bloom

Floral print womenswear
From leading man to Elephant Man, Bradley Cooper is terrific

From leading man to Elephant Man

Bradley Cooper is terrific
In this the person to restore our trust in the banks?

In this the person to restore our trust in the banks?

Dame Colette Bowe - interview
When do the creative juices dry up?

When do the creative juices dry up?

David Lodge thinks he knows
The 'Cher moment' happening across fashion just now

Fashion's Cher moment

Ageing beauty will always be more classy than all that booty
Thousands of teenage girls enduring debilitating illnesses after routine school cancer vaccination

Health fears over school cancer jab

Shock new Freedom of Information figures show how thousands of girls have suffered serious symptoms after routine HPV injection
Fifa President Sepp Blatter warns his opponents: 'I forgive everyone, but I don't forget'

'I forgive everyone, but I don't forget'

Fifa president Sepp Blatter issues defiant warning to opponents
Extreme summer temperatures will soon cause deaths of up to 1,700 more Britons a year, says government report

Weather warning

Extreme summer temperatures will soon cause deaths of up to 1,700 more Britons a year, says government report
LSD: Speaking to volunteer users of the drug as trials get underway to see if it cures depression and addiction

High hopes for LSD

Meet the volunteer users helping to see if it cures depression and addiction
German soldier who died fighting for UK in Battle of Waterloo should be removed from museum display and given dignified funeral, say historians

Saving Private Brandt

A Belgian museum's display of the skeleton of a soldier killed at Waterloo prompts calls for him to be given a dignified funeral